<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46">
 <label>46.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>King</surname>
    <given-names>JC</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>MM</given-names>
   </name>
   <name>
    <surname>Reisinger</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Hedrick</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Graham</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Patriarca</surname>
    <given-names>P</given-names>
   </name>
  </person-group>. 
  <article-title>Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months</article-title>. 
  <source>Vaccine.</source> (
  <year>2009</year>) 
  <volume>27</volume>:
  <fpage>6589</fpage>â€“
  <lpage>94</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.08.032</pub-id>
  <?supplied-pmid 19716456?>
  <pub-id pub-id-type="pmid">19716456</pub-id>
 </mixed-citation>
</ref>
